Truncating SOX9 Alterations Are Heterozygous Null Alleles in Genome-Stable Colorectal Cancer

Gastro Hep Adv. 2022;1(5):709-713. doi: 10.1016/j.gastha.2022.04.011. Epub 2022 May 2.

G N Duronio¹, X Liang^{1

2}, P Hebbar¹, M Islam¹, S Spisak^{1

3}, N S Sethi^{1

4

5

6}

¹ Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
³ Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁴ Cancer Program, Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, Massachusetts.
⁵ Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁶ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

No abstract available

Grants and funding